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Comments regarding “A Retrospective Study of
Intravascular Ultrasound use in Patients Undergoing
Endovascular Aneurysm Repair: Its Usefulness and
a Description of the Procedure”
The use of Contrast Enhanced Ultrasound for Intra-
procedural EVAR deployment completely eliminates
the need for nephrotoxic iodinated intra-arterial
contrast.Dear Editor,
I was delighted to read your retrospective study using Intra-
vascular Ultrasound (IVUS) during EVAR stent-graft deploy-
ment1 and commend you for describing a technique to
significantly reduce the intra-arterial contrast used. The
availability of EVAR and the number of patients deemed
suitable for these procedures is growing immensely. As
techniques evolve and become more complex, such as
fenestrated and branched grafts, the corresponding proce-
dure times and thus exposure to greater volumes of nephro-
toxic iodinated contrast and radiation2,3 also increases.
I agree that your IVUS technique will help with these
matters but will not eliminate them completely. In 2008 Dr
Dirk Clevert first described the use of real-time intra-oper-
ative microbubble contrast-enhanced ultrasound for EVAR
stent deployment and for post-procedural endoleak detec-
tion4 (both immediate and late as part of a surveillance
programme). I have visited Munich and witnessed this
procedure that requires no intra-arterial contrast but does
require the use of much reduced doses of intra-procedural
angiographic fluoroscopy. More recently the German group
has published their longer experience and refinement of the
technique with a series of 17 patients5 and compared thisDOI of original article: 10.1016/j.ejvs.2010.07.018.group with 20 treated using “conventional EVAR” consisting
of iodine contrast media with intra-operative fluoroscopy.
The use of intra-operative microbubble contrast ultra-
sound for stent deployment completely eliminates to need
for any completion angiography or the use of any intra-
arterial contrast and significantly reducing the radiation
exposure, which IVUS does not appear to match. I look
forward to your further work that you allude to regarding the
combined use of IVUS and ultrasound contrast, but suggest
that this should not be limited to those with a contraindica-
tion to iodinated media but can be applied more widely.
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Response to comments regarding “A Retrospective
Study Of Intravascular Ultrasound Use In Patients
Undergoing Endovascular Aneurysm Repair: Its
Usefulness And A Description Of The Procedure.”
Dear Editor,
We thank Dr. Dindyal for his comments regarding our paper;
we have provided a response regarding the issue that he
had raised, mainly regarding the usefulness of contrast-
enhanced ultrasonography (CEUS).DOI of original article: 10.1016/j.ejvs.2010.12.011.
572 CorrespondenceWe are extremely pleased to obtain his endorsement for
our paper, which reports an intravascular ultrasonography
(IVUS) technique for reducing the use of contrast agents. We
agree that IVUS cannot completely substitute for contrast
agents with regard to completion angiography for detecting
endoleaks and that CEUS with second-generation contrast
agents would be a powerful diagnostic method. The devel-
opment of CEUS with second-generation agents would be
a great boon for patients with renal dysfunction or allergy to
contrast agents. Regretfully, in our country, health insurance
coverage for CEUS with second-generation contrast agents
has only been approved for hepatic diseases; this technique
is a more practical one because of the clear images obtained
and the durability of echo sound waves. Therefore, we plan
to use it in the near future after it is approved.
The complete substitution of conventional contrast
agents with CEUS has 2 disadvantages. Firstly, the reso-
nance in ultrasonography (US) may not be adequate for
detecting the orifices of the aortic branches.
CEUS appears to be adequate for detecting obvious
perigraft leakage and the pooling of endoleaks in the
aneurysmal sac. However, it is important to know which
branch of the aorta is causing the endoleaks.
In addition, we usually check the route (collateral
vessels) of backflow into the sac in order to prepare for
future re-intervention.
The resolution of the currently used CEUS technique may
not be adequate for detecting the lumbar artery or the
median sacral artery, and the artifact of colon gas may
impede precise examination. We agree with yourrecommendation of preoperative simulation with the US
device; however, this requires skills and a lot of experience.
Secondly, evaluation of US imaging results is less
objective than that of fluoroscopy imaging results, i.e. US
imaging can be evaluated by only a small number of tech-
nicians. This is not desirable with respect to the training of
vascular surgeons in our institute for this technique as well
as with respect to the risk-management aspect such as
overlooking minor endoleaks.
However, the combination of CEUS and IVUS would
a powerful weapon for patients with aneurysms, in cases
where there is a contraindication for the use of contrast
agents. Our dream is the real-time three-dimensional
construction of each US cross section during surgery. If this
can be achieved, then CEUS can provide a complete and non-
invasive alternative to contrast agents.
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